Trials / Completed
CompletedNCT00758407
Methylphenidate Treatment of Cancer-Related Fatigue
Placebo Controlled Double Blind Study With Methylphenidate in Treatment of Adults With Cancer-Related Fatigue
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Medice Arzneimittel Pütter GmbH & Co KG · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylphenidate hydrochloride | sustained release, dosage according to an individual titration schedule |
| DRUG | Placebo | dosage according to an individual titration schedule |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2010-01-01
- First posted
- 2008-09-25
- Last updated
- 2010-01-13
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00758407. Inclusion in this directory is not an endorsement.